Mallia Innovations GmbH is the holding company strategically driving the development and commercialization of cosmetic applications and biopharmaceutical therapies of the immune modulatory sCD83 protein, targeting hair growth, hair loss and other dermatological indications, including wound healing.
Subsidiary Mallia Aesthetics GmbH focuses on the development of cosmetic products to stimulate hair growth.
Subsidiary Mallia Therapeutics GmbH focuses on the clinical development of novel therapies for patients suffering from androgenetic alopecia or alopecia areata, among other conditions.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Henkestrasse 91, Erlangen,91052,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mallia.com
- Keywords
- eleva.
- HQ
- Erlangen
Mallia Questions
Mallia's website is http://www.mallia.com
Mallia's LinkedIn profile is https://de.linkedin.com/company/mallia
Mallia has
8 employees.
View email and phone details for 8
employees at Mallia.
Mallia's industry is
Biotechnology Research
Mallia's top competitors are
Cytotronics,
Disruptive Pharma Ab,
Ariceum Therapeutics,
Iama Therapeutics,
Nuvectis Pharma,
Charm Therapeutics,
Eleva,
Booster Therapeutics,
Cryptyx Bioscience,
Northway Biotech.
Mallia's categories are Biotechnology Research
Mallia's founding year is 2023
